PubRank

Shingo Nakamoto

Author PubWeight™ 25.22‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Chromoendoscopy with indigo carmine dye added to acetic acid in the diagnosis of gastric neoplasia: a prospective comparative study. Gastrointest Endosc 2008 1.74
2 Hepatic STAT1-nuclear translocation and interleukin 28B polymorphisms predict treatment outcomes in hepatitis C virus genotype 1-infected patients. PLoS One 2011 1.00
3 Prevalence of hepatitis C virus subgenotypes 1a and 1b in Japanese patients: ultra-deep sequencing analysis of HCV NS5B genotype-specific region. PLoS One 2013 0.97
4 Factors Associated with Inadequate Tissue Yield in EUS-FNA for Gastric SMT. ISRN Gastroenterol 2011 0.92
5 Hepatitis B virus e antigen downregulates cytokine production in human hepatoma cell lines. Viral Immunol 2010 0.90
6 Hepatitis C Virus nonstructural 5A protein inhibits lipopolysaccharide-mediated apoptosis of hepatocytes by decreasing expression of Toll-like receptor 4. J Infect Dis 2011 0.90
7 Emergence of entecavir-resistant mutations in nucleos(t)ide-naive Japanese patients infected with hepatitis B virus: virological breakthrough is also dependent on adherence to medication. Scand J Gastroenterol 2011 0.90
8 Roles of ITPA and IL28B genotypes in chronic hepatitis C patients treated with peginterferon plus ribavirin. Viruses 2012 0.89
9 Hepatitis B virus e antigen physically associates with receptor-interacting serine/threonine protein kinase 2 and regulates IL-6 gene expression. J Infect Dis 2012 0.89
10 Internal ribosomal entry-site activities of clinical isolate-derived hepatitis A virus and inhibitory effects of amantadine. Hepatol Res 2010 0.88
11 Alanine aminotransferase elevation during peginterferon alpha-2a or alpha-2b plus ribavirin treatment. Int J Med Sci 2013 0.88
12 Production of infectious chimeric hepatitis C virus genotype 2b harboring minimal regions of JFH-1. J Virol 2011 0.87
13 Response to peginterferon-alfa 2b and ribavirin in Japanese patients with chronic hepatitis C genotype 2. Dig Dis Sci 2011 0.86
14 Adherence to medication is a more important contributor to viral breakthrough in chronic hepatitis B patients treated with entecavir than in those with Lamivudine. Int J Med Sci 2013 0.85
15 Acute liver failure associated with propylthiouracil in a pregnant 26-year-old woman. Case Rep Gastroenterol 2013 0.83
16 Lipopolysaccharide blocks induction of unfolded protein response in human hepatoma cell lines. Immunol Lett 2013 0.82
17 Possible widespread presence of hepatitis A virus subgenotype IIIA in Japan: Recent trend of hepatitis A causing acute liver failure. Hepatol Res 2011 0.82
18 The assessment of serum hepatitis C virus RNA 12 weeks after the end of treatment using TaqMan polymerase chain reaction is less relevant than after 24 weeks for predicting sustained virological response. Hepatology 2011 0.82
19 Different effects of three interferons L on Toll-like receptor-related gene expression in HepG2 cells. Cytokine 2013 0.81
20 Efficacy of lamivudine or entecavir on acute exacerbation of chronic hepatitis B. Int J Med Sci 2011 0.80
21 Interleukin-29 suppresses hepatitis A and C viral internal ribosomal entry site-mediated translation. Viral Immunol 2012 0.79
22 Platelet count and sustained virological response in hepatitis C treatment. World J Hepatol 2013 0.79
23 Nuclear receptor mRNA expression by HBV in human hepatoblastoma cell lines. Cancer Lett 2011 0.78
24 Knockdown of receptor-interacting serine/threonine protein kinase-2 (RIPK2) affects EMT-associated gene expression in human hepatoma cells. Anticancer Res 2012 0.77
25 Peginterferon Alfa-2a plus ribavirin in Japanese patients infected with hepatitis C virus genotype 2 who failed previous interferon therapy. Int J Med Sci 2012 0.77
26 Effect of occult hepatitis B virus infection on the early-onset of hepatocellular carcinoma in patients with hepatitis C virus infection. Oncol Rep 2013 0.77
27 Development of recombinant hepatitis C virus with NS5A from strains of genotypes 1 and 2. Biochem Biophys Res Commun 2011 0.76
28 Efficacy of lamivudine or entecavir against virological rebound after achieving HBV DNA negativity in chronic hepatitis B patients. Int J Med Sci 2013 0.76
29 IL-28B polymorphisms and treatment response in hepatitis C virus patients with persistently normal alanine aminotransferase. World J Hepatol 2013 0.75
30 [Hepatitis B virus e antigen plays an important role in the treatment for chronic hepatitis B]. Nihon Rinsho 2015 0.75
31 Clinical evaluation of endosonography-guided biliary drainage for patients with the difficulty with placing of internal drainage. Hepatogastroenterology 2010 0.75
32 [New antivirals for hepatitis B virus infection]. Nihon Rinsho 2015 0.75